Cargando…
The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis
Background: Iron deficiency anemia (IDA) is a public health problem worldwide. Shengxuening Tablet (SXN) has been used for the treatment of various types of anemia, attaining high efficacy. Objective: To evaluate the safety of SXN as well as its preventive and therapeutic efficacy against IDA across...
Autores principales: | Zhang, Yanyu, Lv, Yan, Sun, Yan, Li, Yumeng, Wang, Dehao, Niu, Jicong, Zhao, Pei, Zhang, Mei, Wang, Mingjing, Liu, Weiyi, Hu, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669986/ https://www.ncbi.nlm.nih.gov/pubmed/36408243 http://dx.doi.org/10.3389/fphar.2022.1029641 |
Ejemplares similares
-
Shengxuening versus Oral Iron Supplementation for the Treatment of Renal Anemia: A Systematic Review
por: Zeng, Qin, et al.
Publicado: (2020) -
Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients
por: CHENG, XIN, et al.
Publicado: (2016) -
Incidence of Thrombosis at Different Sites During the Follow-Up Period in Essential Thrombocythemia: A Systematic Review and Meta-Analysis
por: Wang, Dehao, et al.
Publicado: (2023) -
Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia
por: Yang, Erpeng, et al.
Publicado: (2022) -
Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia
por: Wang, Dehao, et al.
Publicado: (2023)